The reduction in chronic low-grade inflammation explains many of the metabolic health improvements seen beyond simple weight loss numbers
Cognitive impairment : problems with concentration, memory impairment, brain fog, and difficulties with decision-making
In clinical trials such as SURPASS-2, tirzepatide demonstrated greater efficacy in type 2 diabetes compared to semaglutide 1 mg, with patients achieving substantial reductions in hemoglobin A1c levels and body weight
10 Ter Meulen BC, Maas ET, Vyas A, et al
All peptide therapy programs are based on provider evaluation, medical history, patient goals, and clinical appropriateness
For subcutaneous use only